Wired for What’s Next.
Reach your press release and disclosure targets.
Get more views with multimedia.
Track your results and refine your message.
Be the news everyone talks about.
Latest News
Today is March 19, 2024.
All times in Eastern Daylight Time.
-
Global Market for Quantum Technologies (Quantum Computing, Cryptography, Communications, Sensors, Batteries) 2024-2035 - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)--The "Global Market for Quantum Technologies (Quantum Computing, Cryptography, Communications, Sensors, Batteries) 2024-2035" report has been added to ResearchAndMarkets.com... more »
-
SAN JOSE, Calif.--(BUSINESS WIRE)--Super Micro Computer, Inc. (“Supermicro” or the “Company”) (Nasdaq: SMCI) today announced the launch of a proposed underwritten registered public offering of 2,00... more »
-
LONDON--(BUSINESS WIRE)-- DMO-TAS041/3241/004 The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk A045\24 19 March 2024 PRESS NOTIC... more »
-
Tilak Healthcare Strengthens Its Leadership TeamPARIS--(BUSINESS WIRE)--Tilak Healthcare, a leading company in digital health for the monitoring of chronic eye diseases, announces the appointment of three experts to support the leadership team, ... more »
-
PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid RestenosisPITTSBURGH--(BUSINESS WIRE)--PECA Labs, a medical device company reimagining the field of vascular grafts and valves with durable polymeric cardiovascular devices designed to fit, grow, and last, h... more »
-
AngloGold Ashanti Releases Preliminary Unaudited Condensed Consolidated Financial Statements as of and for the Six Months and the Year Ended 31 December 2023LONDON & DENVER & JOHANNESBURG--(BUSINESS WIRE)--AngloGold Ashanti releases preliminary unaudited condensed consolidated financial statements as of and for the six months and year ended 31 Dec 2023. more »
-
Pembina Pipeline Corporation Receives Canadian Competition Bureau Approval for the Proposed Acquisition of Enbridge’s Interest in Alliance/Aux SableCALGARY, Alberta--(BUSINESS WIRE)--Pembina Pipeline Corporation ("Pembina" or the "Company") (TSX: PPL; NYSE: PBA) is pleased to announce that it has received a "no-action letter" from the Canadian... more »
-
Risk Strategies fait l'acquisition des opérations nord-américaines de H.W. International B.V.BOSTON--(BUSINESS WIRE)--Risk Strategies, l’une des principales sociétés internationales de courtage en assurance spécialisée et de gestion des risques, annonce aujourd’hui l’acquisition de Hugh Wo... more »
-
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint DiseaseCAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule the... more »
-
NEW YORK--(BUSINESS WIRE)--B Capital, a global multi-stage investment firm, today announced the close of B Capital Opportunities Fund II, L.P. (“Opportunities Fund II” or the “Fund”) with aggregate... more »
-
Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation TherapyFRIENDSWOOD, Texas--(BUSINESS WIRE)--Expert consensus article in JCAD recommends framework including DecisionDx-SCC test for adjuvant radiation therapy decision-making in SCC patients. more »
-
GlobalData Report Highlights Staggering Economic Costs for Pennsylvania of $19.9 Billion Due to ObesityNEW YORK--(BUSINESS WIRE)--Obesity and overweight are estimated to have caused a staggering $19.9 billion reduction in Pennsylvania’s economy in 2022, equivalent to 2.2% of the state's gross domest... more »
-
Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UKHYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, announced the launch of Versavo® (bevacizumab) in the United Kingdom (UK). more »
-
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a leading microbiome therapeutics company, today announced that on March 13, 2024, the Compens... more »
-
Solu Therapeutics Appoints Michael Boretti, Ph.D., as Chief Business OfficerMEDFORD, Mass.--(BUSINESS WIRE)--Solu Therapeutics, a biotechnology company focused on developing therapeutics to eliminate disease-driving cells using its CyTaCTM (Cytotoxicity Targeting Chimera) ... more »